These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5289430)

  • 21. Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines.
    Jackman AL; Kelland LR; Kimbell R; Brown M; Gibson W; Aherne GW; Hardcastle A; Boyle FT
    Br J Cancer; 1995 May; 71(5):914-24. PubMed ID: 7537518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synchronization and recruitment in acute leukemia.
    Lampkin BC; Nagao T; Mauer AM
    J Clin Invest; 1971 Oct; 50(10):2204-14. PubMed ID: 5286686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interference by antifolate drugs in a folate competitive protein-binding assay.
    Hardcastle A; Clarke S; Aherne W
    Cancer Chemother Pharmacol; 1997; 39(6):552-3. PubMed ID: 9118469
    [No Abstract]   [Full Text] [Related]  

  • 25. Quinazoline antifolates with dual biochemical loci of action. Biochemical and biological studies directed towards overcoming methotrexate resistance.
    Calvert AH; Jones TR; Dady PJ; Grzelakowska-Sztabert B; Paine RM; Taylor GA; Harrap KR
    Eur J Cancer (1965); 1980 May; 16(5):713-22. PubMed ID: 7389797
    [No Abstract]   [Full Text] [Related]  

  • 26. New dose-time relationships of folate antagonists to sustain inhibition of human lymphoblasts and leukemic cells in vitro.
    Sedwick WD; Kutler M; Frazer T; Brown OE; Laszlo J
    Cancer Res; 1979 Sep; 39(9):3612-8. PubMed ID: 314333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1973 Jun; 33(6):1290-4. PubMed ID: 4718678
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo effects of methotrexate. Inhibition of DNA synthesis and cell death in sensitive and resistant L1210 ascites populations.
    Hofer KG
    Chemotherapy; 1972; 17(1):59-70. PubMed ID: 5009468
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of 5-fluorouracil on 5-fluorodeoxyuridine 5'-monophosphate and 2-deoxyuridine 5'-monophosphate pools, and DNA synthesis in solid mouse L1210 and rat Walker 256 tumors.
    Klubes P; Connelly K; Cerna I; Mandel HG
    Cancer Res; 1978 Aug; 38(8):2325-31. PubMed ID: 667828
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on agranulocytosis. IX. A biochemical defect in chlorpromazine-sensitive marrow cells.
    Pisciotta AV
    J Lab Clin Med; 1971 Sep; 78(3):435-48. PubMed ID: 5092863
    [No Abstract]   [Full Text] [Related]  

  • 31. Growth rate and cell kill.
    Hryniuk WM; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():330-42. PubMed ID: 5289425
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of membrance transport in the pharmacologic action of antifolates.
    Sirotnak FM
    Cancer Treat Rep; 1981; 65 Suppl 1():19-27. PubMed ID: 7326662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological effects of folic acid antagonists with antineoplastic activity.
    Jackson RC
    Pharmacol Ther; 1984; 25(1):61-82. PubMed ID: 6387725
    [No Abstract]   [Full Text] [Related]  

  • 34. Inactivation by mouse serum of a tightly bound inhibitor of dihydrofolate reductase.
    Fölsch E; Bertino JR
    Mol Pharmacol; 1970 Jan; 6(1):93-8. PubMed ID: 5535872
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of perfusion with amethopterin on L1210 leukemia cells in spin filter culture.
    Thayer PS; Himmelfarb P; Roberts D
    Cancer Res; 1970 Jun; 30(6):1709-14. PubMed ID: 5457937
    [No Abstract]   [Full Text] [Related]  

  • 36. Further evidence for a basis of selective activity and relative responsiveness during antifolate therapy of murine tumors.
    Sirotnak FM; Donsback RC
    Cancer Res; 1975 Jul; 35(7):1737-44. PubMed ID: 1169115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative metabolic fates of thymine nucleotides in human cells.
    Taheri MR; Wickremasinghe RG; Hoffbrand AV
    Biochem J; 1981 Feb; 194(2):451-61. PubMed ID: 6946767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folate reductase of the amethopterin-resistant Streptococcus faecium var. durans-Ak. I. Inhibition by amethopterin and methasquin, a new quinazoline antifolate.
    Albrecht AM; Hutchison DJ
    Mol Pharmacol; 1970 Jul; 6(4):323-34. PubMed ID: 4393363
    [No Abstract]   [Full Text] [Related]  

  • 39. Uptake of tritiated folates by human bone marrow cells in vitro.
    Corcino JJ; Waxman S; Herbert V
    Br J Haematol; 1971 May; 20(5):503-9. PubMed ID: 5579453
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of triamterene on nucleic acid synthesis.
    Chang JC; Hall TC
    Clin Pharmacol Ther; 1972; 13(3):372-6. PubMed ID: 5026377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.